Join
Live feed
·
INSIDERFilingvia Quantisnow
NewAmsterdam Pharma Company N.V. logo

Chief Executive Officer Davidson Michael H. was granted 30,992 units of Ordinary Shares, converted options into 38,394 units of Ordinary Shares and sold 12,258 units of Ordinary Shares, increasing direct ownership by 17% to 390,441 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAMS (NewAmsterdam Pharma Company N.V.) and more on Quantisnow.